Blog

Understanding androgenetic alopecia: the role of DHT

Androgenetic alopecia, commonly called male or female pattern hair loss, is the most common form of hair loss globally, affecting approximately 50% of men by age 50 and up to 40% of women during their lifetime. In India, studies suggest the prevalence is significant and rising, with younger onset increasingly common due to lifestyle, stress, and dietary factors.

The primary driver of androgenetic alopecia is DHT, dihydrotestosterone. DHT is produced when the enzyme 5-alpha reductase (5-AR) converts testosterone into this more potent androgen at the scalp follicle. DHT then binds to androgen receptors in the dermal papilla, the control centre of the hair follicle, and initiates a progressive process called follicle miniaturisation.

Miniaturisation works like this: with each successive hair cycle, the anagen (growth) phase becomes shorter, the hair produced becomes progressively finer and shorter, and eventually the follicle produces only vellus hairs, the fine, barely visible hairs that look like baldness. The follicle is not dead; it is still alive and producing hair, but the hair it makes is so fine it is essentially invisible. This is why androgenetic alopecia is progressive and why starting intervention early produces dramatically better outcomes than waiting.

Two types of 5-alpha reductase exist: Type I (found primarily in skin and sebaceous glands) and Type II (found predominantly in hair follicles and is the primary driver of androgenetic alopecia). Finasteride inhibits Type II selectively. Dutasteride inhibits both. Saw palmetto, according to published research, inhibits both Type I and Type II, a broader inhibition profile that is shared with dutasteride rather than finasteride, which is one of the reasons it is considered more comprehensive than its modest potency alone might suggest.

What is saw palmetto?

Saw palmetto (Serenoa repens) is a small palm plant native to the southeastern United States, particularly Florida and Georgia. It produces dark berries that have been used in Native American medicine for centuries, primarily for urinary and reproductive health. The plant gets its name from the saw-toothed edges of its leaf stems.

In modern use, saw palmetto extract is most widely studied and prescribed for benign prostatic hyperplasia (BPH), an enlarged prostate, where its DHT-reducing effects are directly relevant to prostate tissue. The connection to hair loss followed logically: if saw palmetto reduces DHT in prostate tissue, it should also reduce DHT at the scalp follicle, and clinical trials have confirmed this is indeed the case.

The active compounds responsible for saw palmetto's 5-AR inhibitory activity are its bioactive fatty acids, particularly lauric acid, oleic acid, and myristic acid, along with phytosterols including beta-sitosterol. These fatty acids have been shown to directly bind to and inhibit the 5-alpha reductase enzyme. A 2026 proprietary extraction study found that a standardised concentration of these bioactive fatty acids showed 75-fold greater inhibition of 5-alpha reductase compared with standard saw palmetto extracts, demonstrating how significantly quality and concentration matter between products.

How saw palmetto works on hair loss

Saw palmetto addresses hair loss through three interconnected mechanisms, all centred on DHT modulation but with additional benefits beyond simple enzyme inhibition:

1. Dual 5-alpha reductase inhibition, blocking DHT production

This is the primary and most clinically studied mechanism. Saw palmetto's bioactive fatty acids inhibit both type I and type II 5-alpha reductase, reducing the conversion of testosterone to DHT at the scalp. Less DHT means less binding to androgen receptors in the dermal papilla, less follicle miniaturisation, and slower progression of pattern hair loss. The inhibition is less potent than finasteride, which reduces scalp DHT by approximately 60–70%, while saw palmetto produces more modest reductions, but the clinical trials confirm the effect is meaningful enough to produce measurable improvements in hair count and density.

2. Androgen receptor blocking, a secondary mechanism

Beyond reducing DHT production, saw palmetto has been shown to directly block androgen receptors in hair follicles, preventing DHT from binding even at existing concentrations. This dual action (reducing DHT production AND blocking DHT binding) is more comprehensive than finasteride's single mechanism, which only reduces DHT production. A 2026 critical review in the International Journal of Dermatology (Wiley) noted this dual mechanism as a key reason saw palmetto's clinical effects may be broader than its DHT reduction numbers alone would predict.

3. Anagen phase extension, keeping follicles in growth phase longer

The 2025–2026 clinical trial (PMC12665258) introduced an important additional finding: saw palmetto's bioactive fatty acids extend the anagen (growth) phase of the hair cycle and help maintain the follicular stem cell niche, the reservoir of stem cells from which new follicle cells are generated. A longer anagen phase means each hair grows for more months before shedding, directly resulting in longer, denser hair over time. This mechanism is separate from DHT inhibition and represents an additional pathway through which saw palmetto supports hair retention.

What does the clinical evidence actually say?

Saw palmetto has more clinical trial evidence for hair loss than any other natural ingredient, and the most recent trials are the strongest yet:

2025–2026 RCT in the Journal of Cosmetic Dermatology  Exceptional, Most Recent

The most significant and recent clinical trial on saw palmetto for hair loss was published in the Journal of Cosmetic Dermatology in November 2025 (PMC12665258, Ablon et al.), with 180-day follow-up results published in a second paper in 2026. The study assessed a proprietary bioactive fatty acid extract from saw palmetto (Serenoa repens) in adults with self-perceived hair thinning. Results at 90 days showed statistically significant improvements in hair density, hair shaft diameter, and hair growth rate. The 180-day follow-up confirmed these improvements were sustained and progressive, the longer participants used saw palmetto, the better the results. Importantly, the extract used in this trial showed 75-fold greater 5-alpha reductase inhibition than standard saw palmetto in preclinical testing, confirming that standardised, high-potency extracts produce significantly better outcomes than generic products.

Two-year head-to-head RCT vs finasteride  Strong (Landmark Trial)

The most cited trial in saw palmetto hair loss research was published in the International Journal of Immunopathology and Pharmacology (Rossi et al., 2012), a two-year randomised controlled trial directly comparing saw palmetto extract against finasteride 1mg in men with androgenetic alopecia. The results provided the most honest and useful clinical picture available for saw palmetto: 38% of saw palmetto patients showed improvement in hair count, compared to 68% in the finasteride group. Saw palmetto was less potent, that is clear. But 38% improvement in hair count from a natural, side-effect-free intervention over two years is a clinically meaningful result that justifies its use, particularly for those who cannot or will not use finasteride.

Randomised double-blind placebo-controlled trial, 2002  Strong (Foundational RCT)

The foundational randomised, double-blind, placebo-controlled trial on saw palmetto for androgenetic alopecia (Prager et al., Journal of Alternative and Complementary Medicine, 2002) found that 60% of participants treated with botanical 5-AR inhibitors including saw palmetto showed improvement compared to 11% in the placebo group, a statistically significant result that established saw palmetto's evidence base for hair loss and triggered the subsequent clinical research programme that continues to this day.

2026 critical review, International Journal of Dermatology  Strong (Most Recent Review)

A 2026 critical review published in the International Journal of Dermatology (Wiley, Nguyen et al.), titled "The Over-The-Counter Finasteride Alternative: A Critical Review of Saw Palmetto's Efficacy, Safety, and Regulatory Concerns", provided the most comprehensive and balanced assessment of the current evidence. The review confirmed saw palmetto's dual mechanism (5-AR inhibition plus androgen receptor blocking), acknowledged its lower potency compared to finasteride, but noted its substantially better safety profile and its particular relevance for women, for whom finasteride is not approved, and for men concerned about finasteride's sexual side effects. The review called for larger, better-standardised clinical trials while affirming saw palmetto as a legitimate evidence-based option for mild-to-moderate androgenetic alopecia.

Saw palmetto vs finasteride, the honest comparison

This comparison deserves its own section because it is the question most people with hair loss are actually asking. Here is the most honest, evidence-based answer possible:

The takeaway from this comparison is nuanced and important: saw palmetto is not a replacement for finasteride in advanced hair loss, if someone is losing hair rapidly and significantly, finasteride's superior potency is clinically justified. But for early-to-moderate thinning, for women, for men who have experienced or are concerned about finasteride's side effects, and for anyone wanting a preventive approach before significant loss occurs, saw palmetto's evidence base is strong enough to justify its use as a primary intervention.

Saw palmetto vs other natural DHT blockers

Saw palmetto is not the only natural ingredient studied for DHT inhibition, but it has the strongest human clinical trial evidence of any of them. Here is how it compares:

★ = Saw palmetto. Table compiled from published clinical data as of 2026. The combination of saw palmetto + pumpkin seed oil + rosemary oil addresses DHT inhibition, androgen receptor blocking, scalp circulation, and anti-inflammatory protection simultaneously, making it one of the most comprehensive natural approaches to androgenetic alopecia available without a prescription.

How to use saw palmetto for hair loss

Saw palmetto is available in two primary forms for hair loss, oral supplementation and topical application. Both have clinical evidence, and they work through complementary routes:

Oral supplementation

Topical application in hair oil

Who should (and shouldn't) use saw palmetto for hair loss?

Frequently asked questions

The bottom line

Saw palmetto is the most evidence-backed natural ingredient for androgenetic alopecia available without a prescription. It is the only plant-derived DHT blocker with published randomised controlled trial data, including a direct comparison against finasteride and a 2025 RCT in the Journal of Cosmetic Dermatology showing significant improvements in hair density, shaft diameter, and growth rate at both 90 and 180 days.

The honest position is this: saw palmetto is less potent than finasteride, 38% vs 68% hair count improvement over two years. But it comes with none of finasteride's sexual side effects, requires no prescription, is safe for women, and its dual mechanism of 5-AR inhibition plus androgen receptor blocking gives it a broader action profile than finasteride's single-pathway approach. For the early-to-moderate stages of hair thinning, when the most follicles can still be saved, saw palmetto's evidence justifies it as a genuine first-line natural intervention.

Used consistently, started early, and ideally combined with complementary ingredients that address hair loss through other mechanisms, scalp circulation, follicle nourishment, antioxidant protection, saw palmetto is one of the most rational, evidence-informed decisions someone with androgenetic alopecia can make.